Enhanced Triggering of Local Anesthetic Particles by Photosensitization and Photothermal Effect Using a Common Wavelength
Source abstract
Abstract
On-demand pain relief systems would be very helpful additions to the armamentarium of pain management. Near-infrared triggered drug delivery systems have demonstrated the potential to provide such care. However, challenges remain in making such systems as stimulus-sensitive as possible, to enhance depth of tissue penetration, repeatability of triggering, and safety. Here we developed liposomes containing the local anesthetic tetrodotoxin and also containing a photosensitizer and gold nanorods that were excitable at the same near-infrared wavelength. The combination of triggering mechanisms enhanced the photosensitivity and repeatability of the system in vitro when compared with liposomes with a single photoresponsive component. In vivo, on-demand local anesthesia could be induced with a low irradiance and short irradiation duration, and liposomes containing both photosensitizer and gold nanorods were more effective than those containing just one photoresponsive component. Tissue reaction was benign.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Anesthesia and Neurotoxicity Research · Anesthesia and Pain Management
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Laboratory for Biomaterials and Drug Delivery, Department of Anesthesiology, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts 02115, United States
Funding
National Institutes of Health
References (27)
Show source-provided references
1. 10.1037/a001362810.1037/a0013628 ↗
2. Benyamin R. · Pain Physician · 2008 · 11 · S10510.36076/ppj.2008/11/S105 ↗
3. 10.1016/j.clinthera.2015.03.01710.1016/j.clinthera.2015.03.017 ↗
4. 10.1016/j.mattod.2016.11.01910.1016/j.mattod.2016.11.019 ↗
5. 10.1073/pnas.151879111210.1073/pnas.1518791112 ↗
6. 10.1021/acs.nanolett.5b0344010.1021/acs.nanolett.5b03440 ↗
7. 10.1016/j.nantod.2015.06.00410.1016/j.nantod.2015.06.004 ↗
8. 10.1016/j.jconrel.2017.01.03110.1016/j.jconrel.2017.01.031 ↗
9. 10.1021/ic102209q10.1021/ic102209q ↗
10. 10.1093/jxb/erj18110.1093/jxb/erj181 ↗
11. Ohkawa H. · J. Lipid Res. · 1978 · 19 · 105310.1016/S0022-2275(20)40690-X ↗
12. 10.1021/acs.nanolett.6b0358810.1021/acs.nanolett.6b03588 ↗
13. 10.1039/C0SC00203H10.1039/C0SC00203H ↗
14. 10.1073/pnas.090059810610.1073/pnas.0900598106 ↗
15. Anderson J. M. · Eur. J. Pharm. Biopharm. · 1994 · 40 · 1
16. 10.1002/jbm.126110.1002/jbm.1261 ↗
17. 10.1002/adma.20120462310.1002/adma.201204623 ↗
18. 10.1021/jp051163i10.1021/jp051163i ↗
19. 10.1073/pnas.132265111110.1073/pnas.1322651111 ↗
20. 10.1002/mus.2061810.1002/mus.20618 ↗
21. 10.1016/0304-3940(94)90741-210.1016/0304-3940(94)90741-2 ↗
22. 10.1021/cm020732l10.1021/cm020732l ↗
23. 10.1038/ncomms1043710.1038/ncomms10437 ↗
24. 10.1002/smll.20150084510.1002/smll.201500845 ↗
25. 10.1007/s10895-012-1114-510.1007/s10895-012-1114-5 ↗
26. 10.1016/S1011-1344(96)07349-610.1016/S1011-1344(96)07349-6 ↗
27. 10.1016/j.biomaterials.2014.02.01510.1016/j.biomaterials.2014.02.015 ↗